Fat's secret messengers: could exosomes explain why some obese people stay healthy?

NCT ID NCT05933707

First seen Jul 07, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This study investigates why some people with obesity develop insulin resistance and related diseases while others remain metabolically healthy. Researchers are examining tiny particles called exosomes, released from fat tissue, which may carry signals that affect how cells respond to insulin. The study involves lean individuals and people with obesity, both metabolically healthy and unhealthy, and will test the effects of these exosomes in lab-grown cells and mice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
small extracellular vesicles (exosomes)
What this could lead to
If successful, this research could reveal why some people with obesity are protected from type 2 diabetes and heart disease, potentially pointing toward new prevention strategies.
What could go wrong
This is an early-stage observational study in cells and mice, not a treatment trial. Findings may not translate to humans or lead to any therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Insulin Resistance Obesity obesity disorder Obesity, Metabolically Benign Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.